Colon and Rectal Cancers: Pathologic Staging and Assessment

A Continuing Medical Education Activity sponsored by InforMEDical Communications, Inc.

InforMEDical Communications, Inc. • 83 Acton Street • Carlisle, MA 01741
tel: 978-318-9582 • fax: 978-318-9583 • email: info@informedicalcme.com

References

  • 1.Edge S, Byrd DR, Carducci, et al. (eds.) AJCC Cancer Staging Manual. 7th ed. New York, NY: Springer; 2009.
  • 2.Sobin LH, Gospodarowisz M, Wittekind C (eds.). TNM: Classification of Malignant Tumours. 7th ed. New York, NY: Wiley; 2009.
  • 3.Washington MK, Berlin J, Branton PA, et al. Protocol for the examination of specimens from patients with primary carcinomas of the colon and rectum. Arch Pathol Lab Med 2008; 132:1182-93.
  • 4.Standards and Minimum Datasets for Reporting Common Cancers. Minimum Dataset for Colorectal Cancer Histopathology Reports. London: Royal College of Pathologists, 1998.
  • 5.Commission on Cancer: Cancer Program Standards 2004, Revised Edition. Chicago, American College of Surgeons; 2006.
  • 6.Facility Oncology Registry Data Standards (FORDS): Revised for 2007. Chicago, American College of Surgeons; 2006.
  • 7.U.S. National Institutes of Health, National Cancer Institute Center for Bioinformatics, Cancer Data Standards Repository, Common Data Elements Browser. http://cdebrowser.nci.nih.gov/CDEbrowser, Accessed January 9, 2009.
  • 8.Compton CC, Greene FL. The Staging of Colorectal Cancer. 2004 and Beyond. CA 2004;54:295-308.
  • 9.Compton CC. Key Issues in Reporting Common Cancer Specimens. Problems in Pathologic Staging of Colon Cancer. Arch Pathol Lab Med 2006:130:120-8.
  • 10.Compton CC. Optimal Pathologic Staging for Colon Cancer: Defining Stage II Disease. Clin Cancer Res 2007;22:6862s-70s.
  • 11.Wittekind C, Greene FL, Henson DE (eds). TNM Supplement: A Commentary on Uniform Use. 3rd Ed. New York, NY; Wiley-Liss; 2003.
  • 12.Shepherd N, Baxter K, Love S. The prognostic importance of peritoneal involvement in colonic cancer: A prospective evaluation. Gastroenterology 1997;112:1096-1102.
  • 13.Zeng Z, Cohen AM, Hajdu S, et al. Serosal cytologic study to determine free mesothelial penetration of intraperitoneal colon cancer. Cancer 1992;70:737-40.
  • 14.National Quality Forum. Specifications of the National Voluntary Consensus Standards for Quality of Cancer Care. Pre-Publication draft June 2007. http://www.qualityforum.org/pdf/cancer/txAppA-Specifications_web.pdf, Accessed February 26, 2009.
  • 15.Goldstein NS. Lymph node recoveries from 2,427 pT3 colorectal resection specimens spanning 45 years: Recommendation for a minimum number of recovered lymph nodes based on predictive probabilities. Am J Surg Pathol 2002;26:179-89.
  • 16.Goldstein NS, Sanford W, Coffey M, et al. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma. Trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol 1997;106:209-16.
  • 17.Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed. A secondary survey of Intergroup Trial Int-0089. J Clin Oncol 2003;21:2912-9.
  • 18.Ratto C, Sofo L, Ippoliti M, et al. Accurate lymph-node detection in colorectal specimens resected for cancer is of prognostic significance. Dis Colon Rectum 1999;42:143-58.
  • 19.Burdy G, Panis Y, Alves A, et al. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 2001;44:1682-8.
  • 20.Tepper JE, O'Connell MJ, Niedzwiecki D, et al. Impact of number of nodes retrieved on outcome in patients with rectal cancer. J Clin Oncol 2001;19:157-63.
  • 21.Wong JH, Bowles BJ, Bueno R, et al. Impact of the number of negative nodes on disease-free survival in colorectal cancer. Dis Colon Rectum 2002;45:1341-8.
  • 22.Swanson RS, Compton CC, Stewart AK, et al. The prognosis of T3N0 colon cancer is dependent upon the number of lymph nodes examined. Ann Surg Oncol 2003;10:65-71.
  • 23.Joseph NE, Sigurdson ER, Hanlon AL, et al. Accuracy of determining nodal negativity in colorectal cancer on the basis of the number of nodes retrieved on resection. Ann Surg Oncol 2003;10:213-8.
  • 24.Jestin P, Pahlman L, Glimelius B, et al. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists'specimen examination. Eur J Cancer 2005;41:2071-8.
  • 25.Jestin P, Pahlman L, Glimelius B, et al. Cancer staging and survival in colon cancer is dependent on the quality of the pathologists'specimen examination. Eur J Cancer 2005;41:2071-8.
  • 26.Assad SM, Jubelirer SJ, Welch CA. Prognostic indicators for stage II (Dukes' stage B) adenocarcinoma of the colon. WV Med J 2005;101:210-3.
  • 27.Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: Results of a secondary analysis of a large scale adjuvant trial. Ann Surg 2002;235:458-63.
  • 28.Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer 2005;41:272-9.
  • 29.Miller EA, Woosley J, Martin CF, et al. Hospital-to-hospital variation in lymph node detection after colorectal resection. Cancer 2004;101:1065-71.
  • 30.Wong JH, Johnson S, Hemmings D, et al. Assessing the quality of colorectal cancer staging. Documenting the process in improving the staging of node-negative colorectal cancer. Arch Surg 2005;140:881-7.
  • 31.Tekkis PP, Smith JJ, Heriot AG, et al; on behalf of the Association of Coloproctology of Great Britain and Ireland. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum 2006;49:1673-83.
  • 32.Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: A consecutive cohort study. J Gastrointest Surg 2002;6:883-90.
  • 33.Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel. A French population-based study. Cancer 1998;82:1482-6.
  • 34.Baxter NN, Virnig DJ, Rothenberger DA, et al. Lymph node evaluation in colorectal cancer patients: A population-based study. J Natl Cancer Inst 2005;97:219-25.
  • 35.Nelson H, Petrelli N, Carlin A, et al. Guidelines 200 for colon and rectal surgery. J Natl Cancer Instit 2001;93:583-96.
  • 36.Johnson PM, Malatjalian D, Porter GA. Adequacy of nodal harvest in colorectal cancer: A consecutive cohort study. J Gastrointest Surg 2002;6:883-90.
  • 37.Brown HG, Luckasevic TM, Medich DS, et al. Efficacy of manual dissection of lymph nodes in colon cancer resections. Mod Pathol 2004;17:402-6.
  • 38. Bilchik A, Hoon D, Saha S, et al. Prospective impact of micrometastases in colon cancer: Interim results of a prospective multicenter trial. Ann Surgery 2007;246:568-77.
  • 39.de Haas RJ, Wicherts DA, Hobbelink MG, et al. Sentinel lymph node mapping in colon cancer: Current status. Ann Surg Oncol 2007;14:1070-80.
  • 40.Stojadinovic A, Nissan A, Protic M, et al. Prospective Rrandomized study comparing sentinel lymph node evaluation with standard pathologic evaluation for the staging of colon carcinoma. Results from the United States Military Cancer Institute Clinical Trials Study GI-01. Ann Sugery 2007;245:846-57.
  • 41.Hermanek P, Hutter RV, Sobin LH, et al. International Union Against Cancer. Classification of isolated tumor cells. Cancer 1999;86:2668-73.
  • 42.Singletary SE, Greene FL, Sobin LH. Classification of isolated tumor cells: clarification of the 6th edition of the American Joint Committee on Cancer Staging Manual. Cancer 2003;90:2740-1.
  • 43.Blenkinsopp W, Stewart-Brown S, Blesovsky L, et al. Histopathology reporting in large bowel cancer. J Clin Pathol 1981:34:509-13.
  • 44.Law WL, Chu KW. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients. Ann Surg 2004;240:260-8.
  • 45.Horn A, Dahl O, Morild I. Venous and neural invasion as predictors of recurrence in rectal adenocarcinoma. Dis Colon Rectum 1991;34:798-804.
  • 46.Matsushima T, Mori M, Kido A, et al. Preoperative estimation of neural invasion in rectal carcinoma. Oncol Rep 1998;5:73-6.
  • 47.Bentzen SM, Balslev I, Pedersen M, etal. Time to loco-regional recurrence after resection of Dukes' B and C colorectal cancer with or without adjuvant postoperative radiotherapy. A multivariate regression analysis. Br J Cancer 1992;65:102-7.
  • 48.Ross A, Rusnak C, Weinerman B, et al. Recurrence and survival after surgical management of rectal cancer. Am J Surg 1999;177:392-5.
  • 49.Krasna MJ, Flancbaum L, Cody RP, et al. Vascular and neural invasion in colorectal carcinoma. Incidence and prognostic significance. Cancer 1988;61:1018-23.
  • 50.Shirouzu K, Isomoto H, Kakegawa T. Prognostic evaluation of perineural invasion in rectal cancer. Am J Surg 1993;165:233-7.
  • 51.Onate-Ocana LF, Montesdeoca R, Lopez-Graniel CM, et al. Identification of patients with high-risk lymph node-negative colorectal cancer and potential benefit from adjuvant chemotherapy. Jpn J Clin Oncol 2004;34:323-8.
  • 52.Burdy G, Panis Y, Alves A, e al. Identifying patients with T3-T4 node-negative colon cancer at high risk of recurrence. Dis Colon Rectum 2001;44:1682-8.
  • 53.Horn A, Dahl O, Morild I. The role of venous and neural invasion on survival in rectal adenocarcinoma. Dis Colon Rectum 1990;33:598-601.
  • 54.DiFabio F, Nascimbeni R, Villanacci V, et al. Prognostic variables for cancer-related survival in node-negative colorectal carcinomas. Dig Surg 2004;21:128-33.
  • 55.De Dosso S, Sessa C, Saletti P. Adjuvant therapy for colon cancer : Present and perspectives. Cancer Treat Rev 2008;Nov 12 (Epub ahead of print).
  • 56.Ruo L, Tickoo S, Klimstra DS, et al. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann Surg 2002;236:75-81.
  • 57.Gavioli M, Luppi G, Losi L, et al. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis Colon Rectum 2005;48:1851-7.
  • 58.Ryan R, Gibbons D, Hyland JMP, et al. Pathological response following long-course neoadjuvant chemoradiotherapy for locally advanced rectal cancer. Histopathology 2005;47:141-6.
  • 59.Cross SS, Bull AD, Smith JHF. Is there any justification for the routine examination of bowel resection margins in colorectal adenocarcinoma? J Clin Pathol 1989;42:1040-2.
  • 60.Stocchi L, Nelson H, Sargent DJ, et al. Impact of surgical and pathological variables in rectal cancer: A United States community and cooperative group report. J Clin Oncol 2001;19:3895-3902.
  • 61.Quirke P, Durdy P, Dixon MF, et al. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection. Lancet 1986;II:996-9.
  • 62.Nagtegaal ID, Marijnen CA, Kranenbarg EK, et al.: Pathology Review Committee; Cooperative Clinical Investigators. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002;26:350-7.
  • 63.Marijnen CA, Nagtegaal ID, Kapiteijn E, et al.; Cooperative investigators of the Dutch Colorectal Cancer Group. Radiotherapy does not compensate for positive resection margins in rectal cancer patients: report of a multicenter randomized trial. Int J Radiat Oncol Biol Phys 2003;57:1199-200.
  • 64.Nagtegaal ID, Quirke P. What is the role of the circumferential margin in the modern treatment of rectal cancer? J Clin Onol 2008;26:303-12.
  • 65.Glynne-Jones R, Mawdsley S, Novell JR. The clinical significance o the circumferential resection margin following preoperative pelvic chemo-radiotherapy in rectal cancer: why we need a common language. Colorectal Dis 2006;8:800-7.
  • 66.Wang C, Zhou ZG, Yu YY, et al. Occurrence and prognostic value of circumferential resection margin involvement for patients with rectal cancer. Int J Colorectal Dis. 2009;24:385-90.
  • 67.den Dulk M, Marijnen CA, Putter H, et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007;246:83-90.
  • 68.Bateman AC, Carr NJ, Warren BF. The retroperitoneal surface in distal caecal and proximal ascending colon carcinoma: the Cinderella surgical margin? J Clin Pathol. 2005;58:426-8.
  • 69.den Dulk M, Putter H, Collette L, et al. The abdominoperineal resection itself is associated with an adverse outcome: The European experience based on a pooled analysis of five European randomised clinical trials on rectal cancer. Eur J Cancer 2009 Jan 5. [Epub ahead of print].
  • 70.den Dulk M, Krijnen P, Marijnen CA, et al. Improved overall survival for patients with rectal cancer since 1990: the effects of TME surgery and pre-operative radiotherapy. Eur J Cancer 2008;44:1710-6.
  • 71.Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 2007;246:693-701.
  • 72.Hohenberger W, Matzel KE, Merkel S, et al. Standardised Surgery for Colonic Cancer: Complete mesocolic excision (CME) and central ligation - Technical notes and outcome. Colorectal Dis 2008;Nov 7. [Epub ahead of print].
  • 73.Kapiteijn E, Marijnen CAM, Nagtegaal ID, et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001;345:638-46.
  • 74.Jeyarajah S, Sutton CD, Miller AS, et al. Factors that influence the adequacy of total mesorectal excision for rectal cancer. Colorectal Dis 2007;9:808-15.
  • 75.Hamilton SR, Vogelstein B, Kudo S, et al. Carcinoma of the colon and rectum. In: Hamilton SR, Aaltonen LA, eds. World Health Organization Classification of Tumours. Pathology and Genetics. Tumours of the Digestive System. Lyon: IARC Press; 2000:103-143.
  • 76.Compton CC, Fielding LP, Burgart LJ, et al. Prognostic Factors in Colorectal Cancer: College of American Pathologists consensus statement 1999. Arch Pathol Lab Med 2000;124: 979-94.
  • 77.Compton CC, Fenoglio-Preiser CM, Pettigrew N, et al. American Joint Committee on Cancer Prognostic Factors consensus conference: Colorectal Working Group. Cancer 2000;88:1739-57.
  • 78.Turner RR, Li C, Compton CC. Newer pathologic assessment techniques for colorectal carcinoma. Clin Cancer Res 2007;6871-6s.
  • 79.Greenson JK, Bonner JD, Ben-Yzhak O, et al. Phenotype of microsatellite unstable colorectal carcinomas. Am J Surg Pathol 2003;27:563-70.
  • 80.Bull AD, Biffin AH, Mella J, et al. Colorectal cancer pathology reporting: a regional audit. J Clin Pathol 1997;50:138-42.
  • 81.Rigby K, Brown SR, Lakin G, et al. The use of a proforma improves colorectal cancer pathology reporting. Ann R Coll Surg Engl 1999;81:401-3.
  • 82.Beattie GC, McAdam TK, Elliott S, et al. Improvement in quality of colorectal cancer pathology reporting with standardized proforma – a comparative study. Colorectal Dis 2003;5:558-62.
  • 83.Eon Y, Le Douy JY, Lamer B, et al. Quality and completeness of histopathology reports of rectal cancer resections. Results of an audit in Brittany. Gastroenterol Clin Biol 2006;30:235-40.
  • 84.Chapuis PH, Chan C, Lin BP, et al. Pathology reporting of resected colorectal cancers in New South Wales in 2000. ANZ J Surg 2007;77:963-9.
  • 85.Winn RD, Robinson DR, Farmer KC, et al. Deficiencies in pathological reporting of colorectal cancer in Victoria. ANZ J Surg 2008;78:769-9.
  • 86.Chan NG, Duggal A, Weir MM, et al. Pathological reporting of colorectal cancer specimens: a retrospective survey in an academic Canadian pathology department. J Can Chir 2008;51:284-8.
  • 87.Siriwardana PN, Arunasalam P, Hewavisenthi J, et al. Histopathology reporting in colorectal cancer (CRC): A proforma improves quality. Colorectal Dis 2008 (Epub ahead of print)

< < PREVIOUS